Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Enterprise Value (2023 - 2026)

Rallybio's Enterprise Value history spans 4 years, with the latest figure at -$54.7 million for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 16.45% to -$54.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$54.7 million, a 16.45% increase, with the full-year FY2025 number at -$54.7 million, up 16.45% from a year prior.
  • Enterprise Value hit -$54.7 million in Q4 2025 for Rallybio, up from -$59.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for RLYB hit a ceiling of -$45.7 million in Q2 2025 and a floor of -$169.0 million in Q4 2022.
  • Historically, Enterprise Value has averaged -$94.3 million across 4 years, with a median of -$88.6 million in 2024.
  • The widest YoY moves for Enterprise Value: up 48.37% in 2025, down 16.45% in 2025.
  • Tracing RLYB's Enterprise Value over 4 years: stood at -$169.0 million in 2022, then skyrocketed by 34.95% to -$109.9 million in 2023, then surged by 40.41% to -$65.5 million in 2024, then rose by 16.45% to -$54.7 million in 2025.
  • Business Quant data shows Enterprise Value for RLYB at -$54.7 million in Q4 2025, -$59.3 million in Q3 2025, and -$45.7 million in Q2 2025.